Health IT Analytics June 24, 2020
The agency is participating in the COVID-19 Diagnostics Evidence Accelerator, which utilizes real-world data to accelerate solutions for the virus.
The Food and Drug Administration (FDA) is leveraging real-world data to better understand COVID-19 risk factors, tailor public health interventions to specific communities, and mitigate the spread of the virus.
For more coronavirus updates, visit our resource page, updated twice daily by Xtelligent Healthcare Media.
The organization is participating in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project that advances the development of diagnostics. The effort is coordinated by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research.
“While there are current studies of viral diagnostic and antibody tests using traditional assessment methods, the Diagnostics...
Today's Sponsors
Today's Sponsor